Basics Relay Therapeutics, Inc. IPO Date: July 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $600.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.66 | 3.38% Avg Daily Range (30 D): $0.09 | 2.77% Avg Daily Range (90 D): $0.11 | 3.82% Institutional Daily Volume Avg Daily Volume: .93M Avg Daily Volume (30 D): 1.41M Avg Daily Volume (90 D): 1.87M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 132 Avg Trade Size (Sh.) (90 D): 152 Institutional Trades Total Inst.Trades: 2,346 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $1.47M Avg Inst. Trade (90 D): $1.22M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.87M Avg Closing Trade (30 D): $1.31M Avg Closing Trade (90 D): $1.12M Avg Closing Volume: 194.01K     News May 27, 2025 @ 1:45 PM Healthcare's Quiet AI Boom Is Creating a New Class... Source: Prnewswire Dec 11, 2024 @ 11:00 AM Relay Therapeutics Announces Updated Interim Data ... Source: N/A Sep 11, 2024 @ 10:46 PM Why Relay Therapeutics Plummeted by Nearly 14% Tod... Source: Eric Volkman Sep 11, 2024 @ 12:21 AM Relay Therapeutics Announces Pricing of Public Off... Source: N/A Jul 17, 2024 @ 12:01 PM Expert Ratings For Relay Therapeutics - Benzinga Source: Benzinga Insights, Benzinga Staff Writer Financials   TTM Q4 2024 FY 2024 Basic EPS $-.46 $-.42 $-2.36 Diluted EPS $-.46 $-.42 $-2.36 Revenue $ 7.68M $ M $ 10.01M Gross Profit $ $ $ Net Income / Loss $ -77.07M $ -76M $ -337.71M Operating Income / Loss $ -84.87M $ -84.98M $ -372.47M Cost of Revenue $ $ $ Net Cash Flow $ M $ -28.07M $ -20.04M PE Ratio